Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sanger Sequencing01:57

Sanger Sequencing

DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
PCR01:32

PCR

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Human gene therapy·2026
Same author

From Idea to Data: An Agentic Architecture for the Clinical Trial Life Cycle.

Studies in health technology and informatics·2026
Same author

LLM-Assisted Clinical Data Harmonization: Combining Automated ETL Generation with Semantic Vocabulary Mapping for OMOP CDM.

Studies in health technology and informatics·2026
Same author

Integration and validation of complementary ex vivo assays for functional precision oncology.

NPJ precision oncology·2026
Same author

Interpretable Feature Extraction from Clinical Notes for Sepsis Prediction: Comparing Rule-Based, LLM, and Hybrid Approaches.

Studies in health technology and informatics·2026
Same author

OMOP Extraction of Medical Text Using LLMs: Preliminary Results.

Studies in health technology and informatics·2026

Related Experiment Video

Updated: May 24, 2026

Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA
11:58

Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA

Published on: June 25, 2014

Insertion site pattern: global approach by linear amplification-mediated PCR and mass sequencing.

Cynthia C Bartholomae1, Hanno Glimm, Christof von Kalle

  • 1Department of Translational Oncology, National Center of Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.

Methods in Molecular Biology (Clifton, N.J.)
|February 28, 2012
PubMed
Summary

Analyzing vector integration sites is crucial for gene therapy biosafety. Linear amplification-mediated PCR (LAM-PCR) combined with next-generation sequencing (NGS) enables sensitive tracking of gene-modified cell clones in clinical trials.

More Related Videos

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites
09:31

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites

Published on: March 22, 2016

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow
12:53

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Published on: June 14, 2017

Related Experiment Videos

Last Updated: May 24, 2026

Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA
11:58

Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA

Published on: June 25, 2014

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites
09:31

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites

Published on: March 22, 2016

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow
12:53

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Published on: June 14, 2017

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Gene therapy utilizes viral or nonviral vectors to deliver corrected genes, but integration sites are often random.
  • Random vector integration can lead to unintended gene deregulation, necessitating comprehensive analysis for biosafety.
  • Vector integration sites serve as unique molecular markers for tracking gene-modified cell clones in vivo.

Purpose of the Study:

  • To highlight the importance of analyzing vector integration sites for gene therapy biosafety.
  • To present Linear Amplification-Mediated PCR (LAM-PCR) as a highly sensitive method for detecting these sites.
  • To emphasize the potential of combining LAM-PCR with Next-Generation Sequencing (NGS) for clinical applications.

Main Methods:

  • Review of existing PCR-based methods for identifying flanking DNA sequences.
  • Focus on Linear Amplification-Mediated PCR (LAM-PCR) for its high sensitivity in detecting multiple integration sites.
  • Integration of LAM-PCR with Next-Generation Sequencing (NGS) platforms.

Main Results:

  • LAM-PCR demonstrates superior sensitivity for detecting diverse vector integration sites within a single sample.
  • LAM-PCR has been validated in preclinical and clinical gene therapy trials for tracking gene-modified cells.
  • The combination of LAM-PCR and NGS enhances the study of clonal composition and pharmacokinetics.

Conclusions:

  • Comprehensive analysis of vector integration sites is essential for assessing gene therapy biosafety.
  • LAM-PCR is a robust and sensitive tool for identifying vector integration sites.
  • LAM-PCR coupled with NGS provides powerful capabilities for monitoring gene therapy efficacy and safety in clinical settings.